How melanoma and other tumors succeed in hiding and resisting immunotherapy
Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...
EurekAlert!1d
CNIO research reveals how melanoma and other tumours succeed in hiding and resisting immunotherapy
Melanoma cells, the most aggressive form of skin cancer, produce a protein that blocks the recognition and removal of the ...
EMBO Press1d
Soluble CD27 differentially predicts resistance to anti-PD1 alone but not with anti-CTLA-4 in melanoma
Predictive biomarkers of immunotherapy response are critical for clinical practice. In this study, baseline plasma sCD27 was ...
EurekAlert!3d
Inhibition of PCSK9: a promising enhancer for anti-PD-1/PD-L1 immunotherapy
Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...
Researchers identify potential drug combinations to improve breast cancer treatment: Q&A with professor of pharmacology
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...
Hosted on MSN1mon
Therapeutic cancer vaccine may improve tumor response to immune checkpoint blockade treatments
Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune system recognize cancer cells that are masquerading as healthy cells. T cells are built ...
Nanowerk10d
Smart nanotherapy enhances immune attack on melanoma
Researchers developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma - a ...